{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:32:55Z","timestamp":1793406775041,"version":"4.5.0"},"reference-count":113,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:p>Dry eye disease (DED) is a broad term that includes a diverse group of clinical disorders. Aqueous-deficient dry eye (ADDE), a subtype of DED, is characterized by decreased tear production by the lacrimal gland. It can be seen in up to one-third of individuals with DED and can be comorbid with a systemic autoimmune process or occur secondary to an environmental insult. Since ADDE can be a source of long-term suffering and severe visual impairment, early identification and adequate treatment are imperative. Multiple etiologies can underlie ADDE, and it is critical to identify the underlying cause to not only improve the ocular health but also to improve the overall quality of life and well-being of affected individuals. This review discusses the various etiologies of ADDE, highlights a pathophysiology-based approach for evaluating underlying contributors, outlines various diagnostic tests, and reviews treatment options. We present the current standards and discuss ongoing research in this field. Through this review, we propose a treatment algorithm that would be useful for an ophthalmologist in diagnosing and managing individuals with ADDE.<\/jats:p>","DOI":"10.4103\/ijo.ijo_2808_22","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T11:10:52Z","timestamp":1680952252000},"page":"1332-1347","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":54,"title":["Aqueous-deficient dry eye disease: Preferred practice pattern guidelines on clinical approach, diagnosis, and management"],"prefix":"10.4103","volume":"71","author":[{"given":"Pragnya R","family":"Donthineni","sequence":"first","affiliation":[{"name":"The Cornea Institute, KAR Campus, L V Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya B","family":"Doctor","sequence":"additional","affiliation":[{"name":"The Cornea Institute, KAR Campus, L V Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna","family":"Shanbhag","sequence":"additional","affiliation":[{"name":"The Cornea Institute, KAR Campus, L V Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Kate","sequence":"additional","affiliation":[{"name":"The Cornea Institute, KVC Campus, L V Prasad Eye Institute, Vijaywada, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Galor","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA"},{"name":"Surgical Services, Miami Veterans Affairs Medical Center, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali R","family":"Djalilian","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Singh","sequence":"additional","affiliation":[{"name":"Ophthalmic Plastic Surgery Services, KAR Campus, L V Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayan","family":"Basu","sequence":"additional","affiliation":[{"name":"The Cornea Institute, KAR Campus, L V Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jtos.2019.02.007","article-title":"Incidence, demographics, types and risk factors of dry eye disease in India:Electronic medical records driven big data analytics report I","volume":"17","author":"Donthineni","year":"2019","journal-title":"Ocul Surf"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1586\/17469899.2015.1061431","article-title":"Understanding the true burden of dry eye disease","volume":"10","author":"Galor","year":"2015","journal-title":"Expert Rev Ophthalmol"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II report executive summary","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","article-title":"Sj\u00f6gren's syndrome:A systemic autoimmune disease","volume":"22","author":"Negrini","year":"2022","journal-title":"Clin Exp Med"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome:A revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League against rheumatism classification criteria for primary Sj\u00f6gren's syndrome:A consensus and data-driven methodology involving three International patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/1756-185X.13839","article-title":"Update on disease pathogenesis, diagnosis, and management of primary Sj\u00f6gren's syndrome","volume":"23","author":"Wang","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"5928232","DOI":"10.1155\/2021\/5928232","article-title":"Advances in pathogenesis of Sj\u00f6gren's syndrome","volume":"2021","author":"Tian","year":"2021","journal-title":"J Immunol Res"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1080\/09273948.2021.1939390","article-title":"A review of ocular graft-versus-host disease:Pathophysiology, clinical presentation and management","volume":"29","author":"Carreno-Galeano","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4103\/ijo.IJO_2016_20","article-title":"Update on ocular graft-versus-host disease","volume":"69","author":"Nair","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1038\/srep03419","article-title":"International chronic ocular graft-vs-host-disease (GVHD) consensus group:Proposed diagnostic criteria for chronic GVHD (Part I)","volume":"3","author":"Ogawa","year":"2013","journal-title":"Sci Rep"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.4103\/ijo.IJO_604_20","article-title":"Chronic cicatrizing conjunctivitis:A review of the differential diagnosis and an algorithmic approach to management","volume":"68","author":"Vazirani","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jtos.2015.10.002","article-title":"Stevens-Johnson syndrome\/toxic epidermal necrolysis--A comprehensive review and guide to therapy. I. Systemic disease","volume":"14","author":"Kohanim","year":"2016","journal-title":"Ocul Surf"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/0378-6323.110749","article-title":"A systematic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population","volume":"79","author":"Patel","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1089\/wound.2019.0977","article-title":"Toxic epidermal necrolysis and Steven-Johnson syndrome:A comprehensive review","volume":"9","author":"Charlton","year":"2020","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jtos.2016.02.001","article-title":"Acute and chronic ophthalmic involvement in Stevens-Johnson syndrome\/toxic epidermal necrolysis - A comprehensive review and guide to therapy. II. Ophthalmic disease","volume":"14","author":"Kohanim","year":"2016","journal-title":"Ocul Surf"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/bjophthalmol-2019-314928","article-title":"Clinical clues predictive of Stevens-Johnson syndrome as the cause of chronic cicatrising conjunctivitis","volume":"104","author":"Shanbhag","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ophtha.2020.08.016","article-title":"Lacrimal gland involvement in severe dry eyes after Stevens-Johnson syndrome","volume":"128","author":"Singh","year":"2021","journal-title":"Ophthalmology"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jtos.2022.02.004","article-title":"Drug induced cicatrizing conjunctivitis:A case series with review of etiopathogenesis, diagnosis and management","volume":"24","author":"Singh","year":"2022","journal-title":"Ocul Surf"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2018.04.003","article-title":"Neurotrophic keratopathy","volume":"66","author":"Dua","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"R22-20240828","first-page":"1","article-title":"Ocular involvement in facial nerve paralysis:Risk factors for severe visual impairment and ocular surface exposure in 1870 patients","volume":"2022","author":"Singh","journal-title":"Orbit"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1007\/s10792-019-01110-y","article-title":"Diabetes mellitus is associated with dry eye syndrome:A meta-analysis","volume":"39","author":"Yoo","year":"2019","journal-title":"Int Ophthalmol"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bjophthalmol-2014-306280","article-title":"Ocular neuropathic pain","volume":"100","author":"Rosenthal","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"R25-20240828","article-title":"Congenital alacrimia with lacrimal gland hypoplasia","volume":"1","author":"Singh","year":"2021","journal-title":"Orbit"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaapos.2017.11.003","article-title":"Alacrima, a rare cause of pediatric dry eye","volume":"22","author":"Gupta","year":"2018","journal-title":"J AAPOS"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jtos.2019.07.002","article-title":"Evaluation of strip meniscometry, tear meniscus height and depth in the diagnosis of dry eye disease in asian Indian eyes","volume":"17","author":"Singh","year":"2019","journal-title":"Ocul Surf"},{"issue":"Suppl 11","key":"R29-20240828","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1097\/ICO.0000000000000583","article-title":"Diagnosis of dry eye by tear meniscus measurements using anterior segment swept source optical coherence tomography","volume":"34","author":"Akiyama","year":"2015","journal-title":"Cornea"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1111\/j.1755-3768.2012.02413.x","article-title":"The diagnostic significance of Fourier-domain optical coherence tomography in Sj\u00f6gren syndrome, aqueous tear deficiency and lipid tear deficiency patients","volume":"90","author":"Qiu","year":"2012","journal-title":"Acta Ophthalmol"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00003226-200404000-00010","article-title":"The repeatability of clinical measurements of dry eye","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"key":"R32-20240828","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1167\/iovs.05-0802","article-title":"Strip meniscometry:A new and simple method of tear meniscus evaluation","volume":"47","author":"Dogru","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R33-20240828","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1167\/iovs.10-5986","article-title":"The efficacy, sensitivity, and specificity of strip meniscometry in conjunction with tear function tests in the assessment of tear meniscus","volume":"52","author":"Ibrahim","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R34-20240828","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/bjophthalmol-2020-316929","article-title":"Palpebral lobe of the human lacrimal gland:Morphometric analysis in normal versus dry eyes","volume":"105","author":"Singh","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"R35-20240828","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/bjophthalmol-2020-318159","article-title":"Tear secretion from the lacrimal gland:Variations in normal versus dry eyes","volume":"106","author":"Singh","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"R36-20240828","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jtos.2019.01.004","article-title":"Review and analysis of grading scales for ocular surface staining","volume":"17","author":"Begley","year":"2019","journal-title":"Ocul Surf"},{"key":"R37-20240828","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"key":"R38-20240828","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/ICO.0000000000002311","article-title":"Ocular clinical signs and diagnostic tests most compatible with keratoconjunctivitis sicca:A latent class approach","volume":"39","author":"Gonzales","year":"2020","journal-title":"Cornea"},{"key":"R39-20240828","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archopht.1973.01000040105007","article-title":"Factors affecting tear film breakup in normal eyes","volume":"89","author":"Lemp","year":"1973","journal-title":"Arch Ophthalmol"},{"key":"R40-20240828","doi-asserted-by":"crossref","first-page":"DES64","DOI":"10.1167\/iovs.17-23746","article-title":"Short tear film breakup time-type dry eye","volume":"59","author":"Tsubota","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R41-20240828","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajo.2017.05.022","article-title":"Classification of fluorescein breakup patterns:A novel method of differential diagnosis for dry eye","volume":"180","author":"Yokoi","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R42-20240828","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/ICO.0b013e3182714425","article-title":"Assessment of tear film stability in dry eye with a newly developed keratograph","volume":"32","author":"Hong","year":"2013","journal-title":"Cornea"},{"key":"R43-20240828","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/OPX.0000000000000023","article-title":"Noninvasive tear breakup times and ocular surface disease","volume":"90","author":"Fuller","year":"2013","journal-title":"Optom Vis Sci"},{"key":"R44-20240828","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00006324-199501000-00004","article-title":"The relation between invasive and noninvasive tear break-up time","volume":"72","author":"Cho","year":"1995","journal-title":"Optom Vis Sci"},{"key":"R45-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-021-02233-6","article-title":"Analysis of the first tear film break-up point in Sj\u00f6gren's syndrome and non-Sj\u00f6gren's syndrome dry eye patients","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"R46-20240828","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.exer.2007.01.018","article-title":"Assay of mucins in human tear fluid","volume":"84","author":"Spurr-Michaud","year":"2007","journal-title":"Exp Eye Res"},{"key":"R47-20240828","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/ceo.13924","article-title":"Can in vivo confocal microscopy differentiate between sub-types of dry eye disease?A review","volume":"49","author":"Hwang","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"key":"R48-20240828","first-page":"1","article-title":"Confocal microscopy abnormalities preceding antibody positivity and manifestations of Sjogren's syndrome","volume":"2022","author":"Mercado","journal-title":"Ocul Immunol Inflamm"},{"key":"R49-20240828","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1038\/s41598-020-62583-x","article-title":"Utility of tear osmolarity measurement in diagnosis of dry eye disease","volume":"10","author":"Tashbayev","year":"2020","journal-title":"Sci Rep"},{"key":"R50-20240828","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ajo.2010.10.032","article-title":"Tear osmolarity in the diagnosis and management of dry eye disease","volume":"151","author":"Lemp","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R51-20240828","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jtos.2020.10.003","article-title":"Matrix metalloproteinase 9 positivity predicts long term decreased tear production","volume":"19","author":"Soifer","year":"2021","journal-title":"Ocul Surf"},{"key":"R52-20240828","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jtos.2015.12.007","article-title":"Dry eye profiles in patients with a positive elevated surface matrix metalloproteinase 9 point-of-care test versus negative patients","volume":"14","author":"Lanza","year":"2016","journal-title":"Ocul Surf"},{"key":"R53-20240828","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.ophtha.2016.07.028","article-title":"Matrix Metalloproteinase 9 testing in dry eye disease using a commercially available point-of-care immunoassay","volume":"123","author":"Messmer","year":"2016","journal-title":"Ophthalmology"},{"key":"R54-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(01)00015-5","article-title":"MMPs in the eye:Emerging roles for matrix metalloproteinases in ocular physiology","volume":"21","author":"Sivak","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"R55-20240828","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jtos.2018.05.001","article-title":"Severity, therapeutic, and activity tear biomarkers in dry eye disease:An analysis from a phase III clinical trial","volume":"16","author":"Pinto-Fraga","year":"2018","journal-title":"Ocul Surf"},{"key":"R56-20240828","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biochi.2008.07.007","article-title":"Role of lactoferrin in the tear film","volume":"91","author":"Flanagan","year":"2009","journal-title":"Biochimie"},{"key":"R57-20240828","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1755-3768.1994.tb02791.x","article-title":"Ocular surface damage and tear lactoferrin in dry eye syndrome","volume":"72","author":"Danjo","year":"1994","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R58-20240828","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jtos.2018.11.001","article-title":"A novel and innovative paper-based analytical device for assessing tear lactoferrin of dry eye patients","volume":"17","author":"Sonobe","year":"2019","journal-title":"Ocul Surf"},{"key":"R59-20240828","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s12026-019-09087-7","article-title":"Ocular mucous membrane pemphigoid:A review","volume":"67","author":"Taurone","year":"2019","journal-title":"Immunol Res"},{"key":"R60-20240828","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"issue":"3 Suppl","key":"R61-20240828","first-page":"S88","article-title":"Management of dry eye disease","volume":"14","author":"Lemp","year":"2008","journal-title":"Am J Manag Care"},{"key":"R62-20240828","first-page":"Cd009729","article-title":"Over the counter (OTC) artificial tear drops for dry eye syndrome","volume":"2","author":"Pucker","year":"2016","journal-title":"Cochrane Database syst Rev"},{"key":"R63-20240828","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jop.2019.0060","article-title":"The immunological basis of dry eye disease and current topical treatment options","volume":"36","author":"Periman","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"key":"R64-20240828","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/DDDT.S207743","article-title":"An updated systematic review with meta-analysis of randomized trials on topical cyclosporin A for dry-eye disease","volume":"14","author":"Tuan","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"R65-20240828","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11095-018-2556-5","article-title":"Ocular pharmacokinetics of a topical ophthalmic nanomicellar solution of cyclosporine (Cequa\u00ae) for dry eye disease","volume":"36","author":"Mandal","year":"2019","journal-title":"Pharm Res"},{"key":"R66-20240828","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/0976-500X.195920","article-title":"Lifitegrast:A novel drug for treatment of dry eye disease","volume":"7","author":"Abidi","year":"2016","journal-title":"J Pharmacol Pharmacother"},{"key":"R67-20240828","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.3390\/ijms21082758","article-title":"A multivalent ICAM-1 binding nanoparticle which Inhibits ICAM-1 and LFA-1 interaction represents a new tool for the investigation of autoimmune-mediated dry eye","volume":"21","author":"Hsueh","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R68-20240828","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2147\/OPTH.S110557","article-title":"Development of lifitegrast:A novel T-cell inhibitor for the treatment of dry eye disease","volume":"10","author":"Semba","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"R69-20240828","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/ICO.0000000000000803","article-title":"Safety of lifitegrast ophthalmic solution 5.0% in patients with dry eye disease:A 1-year, multicenter, randomized, placebo-controlled study","volume":"35","author":"Donnenfeld","year":"2016","journal-title":"Cornea"},{"key":"R70-20240828","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/ICO.0b013e318299549c","article-title":"Long-term supplementation With n-6 and n-3 PUFAs improves moderate-to-severe keratoconjunctivitis sicca:A randomized double-blind clinical trial","volume":"32","author":"Sheppard","year":"2013","journal-title":"Cornea"},{"key":"R71-20240828","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2249.2010.04232.x","article-title":"Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo","volume":"162","author":"Rogers","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"R72-20240828","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s40265-015-0409-7","article-title":"Diquafosol ophthalmic solution 3%:A review of its use in dry eye","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"key":"R73-20240828","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10384-013-0251-y","article-title":"Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye","volume":"57","author":"Koh","year":"2013","journal-title":"Jpn J Ophthalmol"},{"key":"R74-20240828","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2147\/OPTH.S40798","article-title":"Rebamipide ophthalmic suspension for the treatment of dry eye syndrome:A critical appraisal","volume":"8","author":"Kashima","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"R75-20240828","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.ophtha.2012.06.052","article-title":"Rebamipide (OPC-12759) in the treatment of dry eye:A randomized, double-masked, multicenter, placebo-controlled phase II study","volume":"119","author":"Kinoshita","year":"2012","journal-title":"Ophthalmology"},{"key":"R76-20240828","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/vop.12510","article-title":"Rebamipide suppresses TNF-\u03b1 production and macrophage infiltration in the conjunctiva","volume":"21","author":"Tajima","year":"2018","journal-title":"Vet Ophthalmol"},{"key":"R77-20240828","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/02713683.2013.834939","article-title":"Regulation of human corneal epithelial mucins by rebamipide","volume":"39","author":"Itoh","year":"2014","journal-title":"Curr Eye Res"},{"key":"R78-20240828","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/978-1-4615-0717-8_155","article-title":"Use of cevimeline, a muscarinic M1 and M3 agonist, in the treatment of Sj\u00f6gren's syndrome","volume":"506","author":"Fox","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"R79-20240828","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajo.2004.02.010","article-title":"Therapeutic effect of cevimeline on dry eye in patients with Sj\u00f6gren's syndrome:A randomized, double-blind clinical study","volume":"138","author":"Ono","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R80-20240828","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.159.2.174","article-title":"Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sj\u00f6gren syndrome:A randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group","volume":"159","author":"Vivino","year":"1999","journal-title":"Arch Intern Med"},{"key":"R81-20240828","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ophtha.2021.11.004","article-title":"Efficacy and safety of OC-01 (Varenicline Solution) nasal spray on signs and symptoms of dry eye disease:The ONSET-2 phase 3 randomized trial","volume":"129","author":"Wirta","year":"2022","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"R82-20240828","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/ICO.0b013e31817f3a0e","article-title":"Autologous serum eye drops for the treatment of dry eye diseases","volume":"27","author":"Kojima","year":"2008","journal-title":"Cornea"},{"key":"R83-20240828","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtos.2018.11.009","article-title":"Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation:Results from two pivotal clinical trials","volume":"17","author":"Sheppard","year":"2019","journal-title":"Ocul Surf"},{"key":"R84-20240828","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/tvst.9.12.23","article-title":"Novel extranasal tear stimulation:Pivotal study results","volume":"9","author":"Ji","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"R85-20240828","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jtos.2019.08.004","article-title":"Trehalose augments autophagy to mitigate stress induced inflammation in human corneal cells","volume":"17","author":"Panigrahi","year":"2019","journal-title":"Ocul Surf"},{"key":"R86-20240828","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/ICU.0000000000000768","article-title":"Alternative therapies for dry eye disease","volume":"32","author":"Mittal","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"key":"R87-20240828","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2017.09.031","article-title":"Botulinum toxin A for the treatment of photophobia and dry eye","volume":"125","author":"Diel","year":"2018","journal-title":"Ophthalmology"},{"key":"R88-20240828","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ICO.0000000000002384","article-title":"Long-term outcomes of punctal cauterization in the management of ocular surface diseases","volume":"40","author":"Wang","year":"2021","journal-title":"Cornea"},{"key":"R89-20240828","first-page":"Cd006775","article-title":"Punctal occlusion for dry eye syndrome","volume":"6","author":"Ervin","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R90-20240828","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/08820538.2021.1966059","article-title":"Systemic immunosuppression in cornea and ocular surface disorders:A ready reckoner for ophthalmologists","volume":"37","author":"Kate","year":"2022","journal-title":"Semin Ophthalmol"},{"issue":"Suppl 5","key":"R91-20240828","doi-asserted-by":"crossref","first-page":"v69","DOI":"10.1093\/rheumatology\/keaa403","article-title":"Treating systemic lupus erythematosus in the 21st century:New drugs and new perspectives on old drugs","volume":"59","author":"Ruiz-Irastorza","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R92-20240828","first-page":"3379","article-title":"Ocular cicatricial pemphigoid (Review)","volume":"20","author":"Branisteanu","year":"2020","journal-title":"Exp Ther Med"},{"key":"R93-20240828","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.all.0000244799.33734.d4","article-title":"Ocular cicatricial pemphigoid","volume":"6","author":"Hingorani","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R94-20240828","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/bjophthalmol-2020-316611","article-title":"Minor salivary gland transplantation for severe dry eye disease due to cicatrising conjunctivitis:Multicentre long-term outcomes of a modified technique","volume":"105","author":"Vazirani","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"R95-20240828","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/08820538.2021.1926518","article-title":"A novel diagnostic technique of measuring labial minor salivary gland secretions using sodium fluorescein dye:Implications for patients with dry eyes","volume":"37","author":"Singh","year":"2022","journal-title":"Semin Ophthalmol"},{"key":"R96-20240828","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/ICO.0000000000002359","article-title":"Functional assessment of transplanted minor salivary glands","volume":"39","author":"Singh","year":"2020","journal-title":"Cornea"},{"key":"R97-20240828","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/OPTO.S144357","article-title":"Therapeutic uses of scleral contact lenses for ocular surface disease:Patient selection and special considerations","volume":"10","author":"Harthan","year":"2018","journal-title":"Clin Optom (Auckl)"},{"key":"R98-20240828","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40265-020-01282-3","article-title":"A Review of management strategies for nociceptive and neuropathic ocular surface pain","volume":"80","author":"Dermer","year":"2020","journal-title":"Drugs"},{"key":"R99-20240828","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/08820538.2015.1114853","article-title":"Understanding neuropathic corneal pain\u2014gaps and current therapeutic approaches","volume":"31","author":"Goyal","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"R100-20240828","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13760-019-01156-w","article-title":"Is gabapentin effective in dry eye disease and neuropathic ocular pain?","volume":"121","author":"Ongun","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"R101-20240828","doi-asserted-by":"crossref","first-page":"788524","DOI":"10.3389\/fphar.2021.788524","article-title":"Differential effects of treatment strategies in individuals with chronic ocular surface pain with a neuropathic component","volume":"12","author":"Patel","year":"2021","journal-title":"Front Pharmacol"},{"key":"R102-20240828","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jtos.2015.01.005","article-title":"Autologous serum tears for treatment of photoallodynia in patients with corneal neuropathy:Efficacy and evaluation with in vivo confocal microscopy","volume":"13","author":"Aggarwal","year":"2015","journal-title":"Ocul Surf"},{"key":"R103-20240828","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jtos.2019.05.006","article-title":"Relationship between the microbiome and ocular health","volume":"17","author":"Cavuoto","year":"2019","journal-title":"ocul Surf"},{"key":"R104-20240828","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","article-title":"The pathophysiology of dry eye disease:What we know and future directions for research","volume":"124","author":"Pflugfelder","year":"2017","journal-title":"Ophthalmology"},{"key":"R105-20240828","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jtos.2019.10.006","article-title":"The gut-eye-lacrimal gland-microbiome axis in Sj\u00f6gren Syndrome","volume":"18","author":"Trujillo-Vargas","year":"2020","journal-title":"Ocul Surf"},{"key":"R106-20240828","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12934-020-01348-7","article-title":"Gut microbial dysbiosis in individuals with Sj\u00f6gren's syndrome","volume":"19","author":"Mendez","year":"2020","journal-title":"Microb Cell Fact"},{"key":"R107-20240828","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jtos.2020.11.013","article-title":"Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease","volume":"19","author":"M\u00f8ller-Hansen","year":"2021","journal-title":"Ocul Surf"},{"key":"R108-20240828","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/mt.2012.208","article-title":"Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease","volume":"20","author":"Weng","year":"2012","journal-title":"Mol Ther"},{"key":"R109-20240828","doi-asserted-by":"crossref","first-page":"DES169","DOI":"10.1167\/iovs.17-23576","article-title":"Regeneration of lacrimal gland function to maintain the health of the ocular surface","volume":"59","author":"Kawakita","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R110-20240828","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40135-017-0142-3","article-title":"Strategies for regenerating the lacrimal gland","volume":"5","author":"Liu","year":"2017","journal-title":"Curr Ophthalmol Rep"},{"key":"R111-20240828","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/02713683.2019.1637438","article-title":"Towards lacrimal gland regeneration:Current concepts and experimental approaches","volume":"45","author":"Dietrich","year":"2020","journal-title":"Curr Eye Res"},{"key":"R112-20240828","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-1-4939-6949-4_11","article-title":"Generation of a bioengineered lacrimal gland by using the organ germ method","volume":"1597","author":"Hirayama","year":"2017","journal-title":"Methods Mol Biol"},{"key":"R113-20240828","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41586-022-04613-4","article-title":"Generation of 3D lacrimal gland organoids from human pluripotent stem cells","volume":"605","author":"Hayashi","year":"2022","journal-title":"Nature"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2808_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:13:18Z","timestamp":1787166798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2808_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":113,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2808_22","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2022-10-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}